Page 57 - Genomic Medicine in Emerging Economies

46 CHAPTER 3: Genomics and Public Health: China’s Perspective

Ngan, F., Shaw, P., But, P., Wang, J., 1999. Molecular authentication of Panax species. Phytochem-
istry 50 (5), 787–791.
Peng, X., Song, S., Sullivan, S., Qiu, J., Wang, W., 2006. Ageing, the urban-rural gap and disability
trends: 19 years of experience in China-1987 to 2006. PLoS One 5 (8), e12129.
Qiong, E., Tang, Z.L., Huang, J.Y., Han, P., Tian, D., Li, C.L., et al., 2008. An analysis on will survey
of prenatal screening for Down syndrome. Chin. Prim. Health Care 8, 33–35.
Ren, A.G., Wang, L.N., Zhao, P., Li, Z., 2002. Current status of genetic counselling in maternal and
child health care institutions. Chin. J. Reprod. Health 13 (3), 131–134.
Roberts, K.D., 1997. China’s “tidal wave” of migrant labor: what can we learn from Mexican un-
documented migration to the United States? Intl. Migr. Rev., 249–293.
Shao, S., Zhao, F., Wang, J., Feng, L., Lu, X., Du, J., et al., 2013. The ecology of medical care in Bei-
jing. PLoS One 8 (12), e82446.
Shaokang, Z., Zhenwei, S., Blas, E., 2002. Economic transition and maternal health care for inter-
nal migrants in Shanghai, China. Health Pol. Plann. 17 (Suppl. 1), 47–55.
Shaw, P.C., But, P.P., 1995. Authentication of Panax species and their adulterants by random-
primed polymerase chain reaction. Planta Med. 61 (05), 466–469.
Shen, J., Huang, Y., 2003. The working and living space of the ‘floating population’ in China. Asia
Pac. Viewpoint 44 (1), 51–62.
Short, S.E., Zhai, F., Xu, S., Yang, M., 2001. China’s one-child policy and the care of children: an
analysis using qualitative and quantitative data. Soc. Forces 79 (3), 913–943.
Wang, W., 2016. Genomics and Traditional Chinese Medicine. In: Dhavendra, Kumar., Ruth, Chadwick.
(Eds.), Genetics and Society: Ethical, Legal, Cultural and Socioeconomic Implications. Elsevier.
Wang, P., Chen, Z., 2013. Traditional Chinese medicine ZHENG and omics convergence: a systems
approach to post-genomics medicine in a global world. OMICS 17 (9), 451–459.
Wang, W., Yan, Y., 2012. Suboptimal health: a new health dimension for translational medicine.
Clin. Transl. Med. 1 (1), 28. doi: 10.1186/2001-1326-1-28.
Wang, F., Zuo, X., 1999. Inside China’s cities: institutional barriers and opportunities for urban
migrants. Am. Econ. Rev. 89 (2), 276–280.
Wang, E., Bussom, S., Chen, J., Quinn, C., Bedognetti, D., Lam, W., et al., 2011. Interaction of a
traditional Chinese medicine (PHY906) and CPT-11 on the inflammatory process in the tumor
microenvironment. BMC Med. Genomics 4 (1), 38.
Wang, W., Russell, A., Yan, Y., 2014. Traditional Chinese medicine and new concepts of predictive,
preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA
J. 5 (1), 4.
Wang, Y., Adua, E., Russell, A., Roberts, P., Ge, S., Zeng, Q., et al., 2016a. Glycomics and its applica-
tion potential in precision medicine. Science. doi: 10.1126/science.354.6319.1601-b.
Wang, Y., Klaric, L., Yu, X., Thaqi, K., Dong, J., Novokmet, M., et al., 2016b. The association be-
´
tween glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional
study. Medicine 95 (17).
Wang, Y., Ge, S., Yan, Y., Wang, A., Zhao, Z., Yu, X., et al., 2016c. China suboptimal health cohort
study: rationale, design and baseline characteristics. J. Transl. Med. 14 (1), 291.
Wang, Y., Liu, X.X., Qiu, J., Wang, H., Di, Liu., et al., 2017. Association between Ideal Cardiovascu-
lar Health Metrics and Suboptimal Health Status in Chinese Population. Scientific Reports 7,
14975. doi: 10.1038/s41598-017-15101-5.
Wasser, S.P., 2002. Medicinal mushrooms as a source of antitumor and immunomodulating poly-
saccharides. Appl. Microbiol. Biotechnol. 60 (3), 258–274.